Compare NUTX & CDNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NUTX | CDNA |
|---|---|---|
| Founded | 2011 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Retail: Computer Software & Peripheral Equipment | Medical Specialities |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 729.5M | 712.2M |
| IPO Year | N/A | 2014 |
| Metric | NUTX | CDNA |
|---|---|---|
| Price | $174.26 | $19.87 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 2 | 7 |
| Target Price | ★ $252.50 | $26.00 |
| AVG Volume (30 Days) | 225.2K | ★ 816.3K |
| Earning Date | 11-19-2025 | 11-04-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 17.98 | 1.22 |
| Revenue | ★ $981,195,633.00 | $357,998,000.00 |
| Revenue This Year | $104.36 | $14.11 |
| Revenue Next Year | $4.10 | $12.00 |
| P/E Ratio | ★ $10.29 | $16.92 |
| Revenue Growth | ★ 236.03 | 14.46 |
| 52 Week Low | $28.12 | $10.96 |
| 52 Week High | $193.00 | $25.95 |
| Indicator | NUTX | CDNA |
|---|---|---|
| Relative Strength Index (RSI) | 62.60 | 66.40 |
| Support Level | $107.09 | $18.36 |
| Resistance Level | $193.00 | $19.95 |
| Average True Range (ATR) | 16.42 | 0.87 |
| MACD | 4.66 | 0.16 |
| Stochastic Oscillator | 78.56 | 75.85 |
Nutex Health Inc is healthcare services and operations company with 20 hospital facilities in eight states (hospital division), and a primary care-centric, risk-bearing population health management division. The hospital division implements and operates healthcare models, including micro-hospitals, specialty hospitals and hospital outpatient departments (HOPDs). The population health management division owns and operates provider networks such as independent physician associations (IPAs) and offers a cloud-based proprietary technology platform to IPAs that aggregates clinical and claims data across multiple settings, information systems and sources to create a holistic view of patients and providers.
CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre- and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically the company generates the majority of its revenue from the United States. The company generates the majority of revenue from the Testing services.